Colcrys for Acute Gout Hickory NC

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

Mobile Vet to Pet Service
(828) 446-9838
Serving Your Area
Granite Falls, NC

Data Provided by:
James Thomas Barker
(828) 324-9900
24 2nd Ave Ne
Hickory, NC
Specialty
Internal Medicine

Data Provided by:
Melissa M Braunsteiner
(828) 326-3809
212 29th Ave Ne
Hickory, NC
Specialty
Family Practice

Data Provided by:
Jan O Koehler
(843) 237-3378
420 N Center St
Hickory, NC
Specialty
Internal Medicine, Emergency Medicine

Data Provided by:
Baxter Leonard
(828) 328-2231
24 2nd Ave Ne
Hickory, NC
Specialty
General Practice

Data Provided by:
Lincoln Chiropractic
(704) 879-1994
108 Newbold St
Lincolnton, NC

Data Provided by:
Robert Eric Hart
(828) 322-8484
221 13th Avenue Pl Nw
Hickory, NC
Specialty
Family Practice

Data Provided by:
Robert Glenn
(828) 328-2231
24 2nd Ave Ne
Hickory, NC
Specialty
General Practice, Family Practice

Data Provided by:
Shane O Summers
(828) 322-8484
221 13th Avenue Pl Nw
Hickory, NC
Specialty
Family Practice

Data Provided by:
James Walter Goforth
(828) 431-4955
2972 N Center St
Hickory, NC
Specialty
Internal Medicine, Emergency Medicine

Data Provided by:
Data Provided by:

Colcrys for Acute Gout

Provided By:

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

In a news release, the agency said colchicine has been used as a remedy to treat acute gout flares "for many years," despite that it hadn't been FDA approved. The agency said it was in the midst of a program to bring other similarly unapproved products under its regulatory authority.

A dosing study required for approval led the agency to recommend a lower dosing regimen for Colcrys that had been commonly prescribed, the news release said. This was designed to prevent gastrointestinal problems.

The FDA said it was alerting healthcare professionals of the lower dosing schedule and also warning that the drug had the potential for severe interactions with other medications.

FMF, common in Mediterranean nations but less so in the United States, has symptoms including fever, arthritis, and inflammation of the lining of the lungs and abdomen. Colcrys is now the first drug that's been FDA-approved to treat FMF, the agency said.

The drug is produced by Philadelphia-based Mutual Pharmaceutical Company Inc.

More information

The FDA has more about this medication's approval.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com